Clinical Trial Update: Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing denosumab to placebo in patients with thalassemia major and osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Thalassemia Major

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Ersi Voskaridou | Conditions: Thalassemia Major, Osteoporosis | Phase 2 | Status: COMPLETED